Department of Discovery Immunology, Genentech, South San Francisco, California, USA.
Nat Immunol. 2013 Dec;14(12):1229-36. doi: 10.1038/ni.2743. Epub 2013 Oct 20.
Type 2 innate lymphoid cells (ILC2 cells) participate in host defense against helminth parasites and in allergic inflammation. Given their functional relatedness to type 2 helper T cells (T(H)2 cells), we explored whether Gfi1 acts as a shared transcriptional determinant in ILC2 cells. Gfi1 promoted the development of ILC2 cells and controlled their responsiveness during infection with Nippostrongylus brasiliensis and protease allergen-induced lung inflammation. Gfi1 'preferentially' regulated the responsiveness of ILC2 cells to interleukin 33 (IL-33) by directly activating Il1rl1, which encodes the IL-33 receptor (ST2). Loss of Gfi1 in activated ILC2 cells resulted in impaired expression of the transcription factor GATA-3 and a dysregulated genome-wide effector state characterized by coexpression of IL-13 and IL-17. Our findings establish Gfi1 as a shared determinant that reciprocally regulates the type 2 and IL-17 effector states in cells of the innate and adaptive immune systems.
2 型固有淋巴细胞 (ILC2 细胞) 参与宿主对寄生虫和过敏炎症的防御。鉴于它们与 2 型辅助 T 细胞 (T(H)2 细胞) 的功能相关性,我们探索了 Gfi1 是否作为 ILC2 细胞中的一个共同转录决定因素发挥作用。Gfi1 促进了 ILC2 细胞的发育,并在感染巴西旋毛虫和蛋白酶过敏原诱导的肺炎症期间控制了它们的反应性。Gfi1 通过直接激活编码 IL-33 受体 (ST2) 的 Il1rl1,“优先”调节了 ILC2 细胞对白细胞介素 33 (IL-33) 的反应性。在活化的 ILC2 细胞中缺失 Gfi1 导致转录因子 GATA-3 的表达受损,并导致一个失调的全基因组效应状态,其特征是 IL-13 和 IL-17 的共表达。我们的研究结果确立了 Gfi1 作为一个共同决定因素,它在先天和适应性免疫系统的细胞中相互调节 2 型和 IL-17 效应状态。